The medtech zwo magazine reports on developments in robot-assisted surgery. The SHS portfolio company AOT has developed an innovative procedure for bone surgery with its laser osteotomy robot Carlo. The robot is able to perform complicated operations on the bone independently under the supervision of a surgeon using a new type of laser cutting process. […]
medtech zwo magazine spoke in an interview with Hubertus Leonhardt, Managing Director and Partner of SHS, about the current situation in the medical technology sector. The SHS Medical Technology Index, which was developed in cooperation between Christan Koziol, Professor and Chair of Finance at the University of Tübingen, and SHS, quantifies developments and industry trends. […]
Early non-invasive detection of kidney rejection after transplantation was the central aim of a collaboration between Prof. Dr. Bernhard Banas, Chairman of Nephrology at the University Hospital Regensburg (UKR) and the medical diagnostics company, numares. The results of their joint clinical trial “UMBRELLA” were just published in EBioMedicine and will be presented right now at the American Society of Nephrology’s […]
Although the performance of the medical technology sector is still well above that of the economy as a whole, the relative growth rate has been in decline for the past two years The Medical Device Regulation introduced in 2017 may have slowed the sector’s growth momentum Small and medium-sized companies in particular require more capital […]
The Börsen-Zeitung covers the publication of the SHS-Medtech-Index and reports on new developments in the industry, with the Medical Device Regulation being a crucial topic. In light of stagnant numbers of patent approvals per year in the Medtech industry, Hubertus Leonhardt is cited by the newspaper. The Managing Partner of SHS states that there is […]
Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO® Impulse System for treatment of STEMI patients. The FDA Breakthrough Device designation is intended to speed time to market for treatments of life-threatening or irreversibly debilitating diseases or conditions and recognizes the novelty […]
The Frankfurter Allgemeine Zeitung reports about the newly issued SHS-Medtech-Index, which was jointly developed by Christian Koziol, Head of the Finance Department of the University of Tübingen, and SHS. The index measures the development of the German Medtech industry in relation to the overall economy since 2010. Four indicators are used: revenue, working population, patents […]
Funding will finance further development and IVD-CE marking of the company’s first molecular POC (Point of Care) platform, based on Pulse Controlled Amplification (PCA) technology.
Die Basler Zeitung berichtet über eine Weltpremiere: Die erste Operation, bei der menschlicher Knochen ausschließlich mit einem robotergesteuerten Laser geschnitten wurde. Philipp Jürgens, leitender Arzt in der Mund-, Kiefer- und Gesichtschirurgie am Universitätsspital Basel, sieht das Potenzial „die Knochenchirurgie zu revolutionieren“. Das innovative Verfahren basiert auf Carlo, einem Laser-Osteotomie Roboter, entwickelt vom SHS-Portfoliounternehmen AOT. Carlo […]
The Venture Capital magazine examines the price level of buyout transactions this spring, with a special focus on medical technology. Experts classify the industry as very promising, but rate the prices as often not justified. Hubertus Leonhardt, Managing Partner at SHS Gesellschaft für Beteiligungsmanagement mbH, points out that buyout transactions are often about more than […]
WirtschaftsWoche reports on the third investment of SHS from its current fund SHS V. Betterguards Technology GmbH, founded in 2014 and headquartered in Berlin with a production facility in Brandenburg, develops and produces intelligent components (so-called adaptors) that can be integrated into sports shoes, bandages or work protection shoes, for example. Equipped with this unique […]
Third investment from fifth SHS fund – development of a diversified portfolio of medical technology and life science companies TTübingen-based medical technology investor SHS Gesellschaft für Beteiligungsmanagement mbH has invested a mid single-digit million amount from its fifth fund in Betterguards Technology GmbH. The technology developed and produced by the Berlin-Brandenburg-based company is primarily aimed […]
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information